Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?
The development of cancer immunotherapy, particularly immune checkpoint blockade therapy, has made major breakthroughs in the therapy of cancers. However, less than one-third of the cancer patients obtain significant and long-lasting therapeutic effects by cancer immunotherapy. Over the past few dec...
Main Authors: | Yingying He, Tao Liu, Shuang Dai, Zihan Xu, Li Wang, Feng Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.739161/full |
Similar Items
-
Structure, Function and Regulation of Versican: The Most Abundant Type of Proteoglycan in the Extracellular Matrix
by: Fattah Sotoodehnejadnematalahi, et al.
Published: (2013-11-01) -
Editorial: Proteoglycans in the Tumor Microenvironment
by: Jlenia Brunetti, et al.
Published: (2022-04-01) -
Editorial: Molecules of the extracellular matrix as cancer targets
by: Nikos K. Karamanos, et al.
Published: (2022-09-01) -
The CNS/PNS Extracellular Matrix Provides Instructive Guidance Cues to Neural Cells and Neuroregulatory Proteins in Neural Development and Repair
by: James Melrose, et al.
Published: (2021-05-01) -
Uncovering Novel Extracellular Matrix Transcriptome Alterations in Lesions of Multiple Sclerosis
by: Erin Laurel Stephenson, et al.
Published: (2024-01-01)